Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
By visiting our site, you agree to our privacy policy regarding cookies, tracking statistics, etc. Read more
Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Recover your password.
A password will be e-mailed to you.
MUMBAI, India, Nov. 11, 2022 /PRNewswire/ — Goldiam International Ltd. (Goldiam), an integrated manufacturer and supplier of fine diamond jewellery to leading retailers and wholesalers in the USA, has announced its results for the second quarter and half year ended on September 30, 2022.
FY23 began with a cautiously optimistic note for the Company on the back of record-breaking inflation in major economies like the USA. High Inflationary scenarios in these economies lead to the postponement of discretionary spending by the consumers and subsequently by the retail customers. The Company has been well prepared for this scenario and strengthened its margin profile to protect the profitability of overall business.
Company’s EBITDA margins for H1FY23 stood at 26.6% higher by 722bps YoY; for Q2FY23 margins stood at 32.5% higher by 1514bps YoY. For H1FY23, Company remained focussed on profitability, by further improving product mix favouring lab-grown diamonds, and by paring down inventory in-stock. The Company maintained its strategy and further strengthened its Lab-grown offerings on all fronts right from designing to rapid deliveries. Integrated operations on Lab-grown diamonds front aided the Company in such inflationary scenario. Thus, on an overall basis, vigilance and integration had a significant contribution to the Company’s resilient performance in H1FY23 vis-a-vis H1FY22.
Financial Highlights (Consolidated) – Q2 & H1 FY23
Particulars (₹ in Mn) |
Q2FY23 |
Q2FY22 |
YoY% |
H1FY23 |
H1FY22 |
YoY% |
Revenue |
927 |
1,748 |
-47 % |
2,338 |
3,299 |
-29 % |
EBITDA |
302 |
304 |
-0.8 % |
622 |
639 |
-3 % |
EBITDA margin |
33 % |
17 % |
1514 bps |
27 % |
19 % |
722bps |
PAT |
188 |
197 |
-4.7 % |
401 |
436 |
-8 % |
Lab-Grown Diamond & Jewellery business-enhancing overall margin profile: Against 15-20% share in FY22, the share of Lab-grown has been consolidating to 25% since the beginning of FY23. This share is expected to improve further as market for Lab-Grown diamonds is expected to grow at a faster rate.
Along with a focus on larger carat diamonds, the Company has focused on integrating these diamonds into its jewellery distribution, thereby securing captive consumption in a rapidly growing industry segment. This also allows Goldiam to enhance offerings as larger cartage of diamonds plays within the premium to super premium bridal category.
Order Book Status ensures Revenue visibility: Goldiam has an order book size of ₹1,500 mn. This order book is expected to be executed in the next four-six months. E-Commerce sales are not part of the order book, given their nature of being booked online (on a spot basis).
Mr. Rashesh Bhansali, Executive Chairman of Goldiam International, commenting on the performance, said, “FY23 started with a global inflationary scenario with various central banks increasing interest rates. This created caution for discretionary spending for weddings, gifts etc. However, the Company was well-prepared for this situation and adjusted its product offerings accordingly. Our investment in Lab-grown diamond facilities continues to reap fundamental benefits. Being a completely integrated player, right from growing diamonds, listing online and delivering it, we have gathered a lot of inherent benefits that makes us highly margin resilient. Our sell down of inventory for natural diamonds has also been beneficial in protecting the overall profitability for the Company, despite such a volatile economic scenario.
The journey of Lab-grown has been accomplishing new milestones for the Company and provides an exciting headroom to grow from hereon. Awareness among domestic consumers is rising for Lab-grown diamond jewellery, and management is evaluating various omnichannel strategies to make an early breakthrough in the domestic market.
With an increasing demand for Lab-Grown Diamonds, Goldiam had carried out a CAPEX to increase its capacity by 40% in FY22. We further expect to double our capacities over FY23 and FY24. The new capacity will be used for Goldiam’s jewellery manufacturing and distribution business, leading to a more robust margin profile. We are confident about the Lab-Grown diamonds business going ahead. This has been further cherry-topped with our omnichannel delivery strategy, making our model even more lucrative for our customers.”
About Goldiam
Goldiam International Limited (NSE: GOLDIAM) (BSE: 526729) is a 3-decade-old preferred OEM partner and exporter of exquisitely designed and luxurious diamond jewellery. Functioning as the manufacturer of choice to many of the leading global branded retailers, departmental stores and wholesalers across American markets, the Company is also renowned for utilising responsibly sourced diamonds, leveraging cutting-edge technologies and efficient manufacturing processes for optimal costings and quick delivery lead times. Targeting the mid-to-affordable diamond & bridal jewellery segments, Goldiam has a dedicated sales office in New York, with design teams in both India and the USA.
Forward-Looking Statement:
Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Goldiam International Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Get real time updates directly on you device, subscribe now.